A Revised Allele Frequency Estimate and Haplotype Analysis of the DBH Deficiency Mutation IVS1 + 2T → C in African- and European-Americans [1]

American Journal of Medical Genetics

Volumn 123 A, Issue 2, 2003, Pages 190-192

  Zabetian, Cyrus P ^a,b   Romero, Roberto ^c   Robertson, David ^d   Sharma, Surendra ^e   Padbury, James F ^e   Kuivaniemi, Helena ^f   Kim, Kwang Soo ^g   Kim, Chun Hyung ^g   Köhnke, Michael D ^h   Kranzler, Henry R ⁱ   Gelernter, Joel ^j,k   Cubells, Joseph F ^j,k  

^a VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^c WAYNE STATE UNIVERSITY   (United States)

^d VANDERBILT UNIVERSITY   (United States)

^e BROWN UNIVERSITY   (United States)

^f WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g MCLEAN HOSPITAL   (United States)

^h UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

ⁱ UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^j YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^k VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DOPAMINE; DOPAMINE BETA MONOOXYGENASE; NORADRENALIN;

ADULT; CONTROLLED STUDY; DOPAMINE BETA MONOOXYGENASE DEFICIENCY; ENZYME DEFICIENCY; ETHNIC GROUP; EUROPEAN AMERICAN; EXERCISE TOLERANCE; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HETEROZYGOTE; HUMAN; LETTER; MAJOR CLINICAL STUDY; MISSENSE MUTATION; NEGRO; ORTHOSTATIC HYPOTENSION; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

EID: 10744226353     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.20300     Document Type: Letter

References (10)

1. Biaggioni I, Goldstein DS, Atkinson T, Robertson D. 1990. Dopamine-beta-hydroxylase deficiency in humans. Neurology 40:370-373.
2. Kim CH, Zabetian CP, Cubells JF, Cho S, Biaggioni I, Cohen BM, Robertson D, Kim KS. 2002. Mutations in the dopamine beta-hydroxylase gene are associated with human norepinephrine deficiency. Am J Med Genet 108:140-147.
3. Kohnke MD, Zabetian CP, Anderson GM, Kolb W, Gaertner I, Buchkremer G, Vonthein R, Schick S, Lutz U, Kohnke AM, Cubells JF. 2002. A genotype-controlled analysis of plasma dopamine beta-hydroxylase in healthy and alcoholic subjects: Evidence for alcohol-related differences in noradrenergic function. Biol Psychiatry 52:1151-1158.
4. Man in 't Veld AJ, Boomsma F, Moleman P, Schalekamp MA. 1987. Congenital dopamine-beta-hydroxylase deficiency. A novel orthostatic syndrome. Lancet 1:183-188.
5. Man in 't Veld A, Boomsma F, Lenders J, vd Meiracker A, Julien C, Tulen J, Moleman P, Thien T, Lamberts S, Schalekamp M. 1988. Patients with congenital dopamine beta-hydroxylase deficiency. A lesson in catecholamine physiology. Am J Hypertens 1:231-238.
6. Mathias CJ, Bannister RB, Cortelli P, Heslop K, Polak JM, Raimbach S, Springall DR, Watson L. 1990. Clinical, autonomic and therapeutic observations in two siblings with postural hypotension and sympathetic failure due to an inability to synthesize noradrenaline from dopamine because of a deficiency of dopamine beta hydroxylase. Q J Med 75:617-633.
7. Robertson D, Goldberg MR, Onrot J, Hollister AS, Wiley R, Thompson JG, Jr. Robertson RM. 1986. Isolated failure of autonomic noradrenergic neurotransmission. Evidence for impaired beta-hydroxylation of dopamine. N Engl J Med 314:1494-1497.
8. Thomas SA, Matsumoto AM, Palmiter RD. 1995. Noradrenaline is essential for mouse fetal development. Nature 374:643-646.
9. Zabetian CP, Gelernter J, Cubells JF. 2000. Functional variants at CYP2A6: New genotyping methods, population genetics, and relevance to studies of tobacco dependence. Am J Med Genet 96:638-645.
10. Zabetian CP, Anderson GM, Buxbaum SG, Elston RC, Ichinose H, Nagatsu T, Kim KS, Kim CH, Malison RT, Gelernter J, Cubells JF. 2001. A quantitative-trait analysis of human plasma-dopamine beta-hydroxylase activity: Evidence for a major functional polymorphism at the DBH locus. Am J Hum Genet 68:515-522.